The Barcelona region features 20 science and technology parks and 60 research centers focused on life science and over 450 companies in the sector
The seventh annual BIO-Europe Spring international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw more than 2,000 C-level executives and key decision makers from over 1,200 companies. Host organizations for the 2013 event are Biocat, the biotechnology, biomedicine and medical technology regional incubator, and the Barcelona City Council.
“The Catalonia region has the infrastructure to support a dynamic life science discovery cluster,” said Carola Schropp, President of EBD Group. “Spain’s biotechnology sector continues to grow. Barcelona’s biotech hub is interested in new public-private partnerships with international companies, and they are committed to the global pursuit of innovation in clinical research and human health.”
“The Barcelona region features 20 science and technology parks and 60 research centers focused on life science, notably the state-of-the-art National Genome Analysis Center, and over 450 companies in the sector,” said Montserrat Vendrell, CEO for Biocat. “The pace of biotechnology progress has really exploded here in Catalonia, and there are a number of companies with projects in Phase I and II trials who are eager to partner. We welcome the global life science to explore the opportunities that are here.” Holding BIO-Europe Spring in Barcelona offers great opportunities to draw technology and knowledge partners to Catalan companies and attract foreign investment, in addition to promoting the country as a leading international business center in the life sciences and innovation.
One-to-one partnering meetings for the 2013 edition in Barcelona can be scheduled prior to the event utilizing partneringONE®, EBD Group’s leading conference networking
solution. The BIO-Europe Spring program will showcase the leading industry decision makers speaking on hot topics of interest to the life science and investment sector. The program also features the popular Therapeutic Insight by Defined Health, one of the leading strategic biopharma business development firms. This program track will have four sessions dedicated to transformative growth opportunities in leading therapeutic categories such as orphan CNS, antibiotics and oncology.
BIO-Europe Spring 2012, held in Amsterdam, The Netherlands, welcomed 2,157 delegates representing 1,304 companies vying for an estimated 2,508 licensing opportunities. 11,172 one-to-one meetings took place at that event between companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
Biocat is the organization that coordinates and promotes the biotechnology, biomedicine and medical technology sector in Catalonia, the BioRegion of Catalonia. Our mission is to dynamize all the stakeholders in this area and their initiatives in order to create an environment with a strong research system, active transfer of knowledge and an entrepreneuring business fabric that can become a driving force for the country’s economy and contribute to the wellbeing of society as a whole.
Biocat promotes collaboration among the stakeholders in the biocluster and a number of organizations both in Catalonia and on a national and international level. Biocat proposes flexible and innovative solutions to the challenges facing the biotechnology, biomedicine and medical technology sector, always seeking the highest quality and efficacy. Biocat’s agenda is clearly client oriented and follows a firm commitment to our objectives and the people.
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include: BIO-Europe and BIO-Europe Spring, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO); BioPharm America, the fastest growing partnering event in North America; Biotech Showcase, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors EuroMedtech, EBD Group’s partnering event for the innovative medical technology industry, and others.
For more information:
Erin Righetti • +1 760 930 0500 • firstname.lastname@example.org
Notes to Editors:
Entry to BIO-Europe Spring 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe Spring conference website at http://www.ebdgroup.com/bes/press_reg.htm for registration details.